US Generic Injectables Market

US Generic Injectables Market Research Report, by Product Type (Monoclonal antibodies, Cytokines, Insulin, Vaccines), Container (Vials, Ampoules, Premix, Prefilled syringes), Application (Oncology, Anaesthesia, Anti-infectives, Cardiovascular), Distribution Channel (Hospital pharmacy, Retail pharmacy, Drug stores, Online stores) – Forecast Till 2030

ID: MRFR/HC/11480-CR | 100 Pages | Author: Garvit Vyas | December 2023         

The demand for generic injectables in the United States is driven by several factors, reflecting the role these medications play in providing cost-effective treatment options for a wide range of medical conditions. Generic injectables are generic versions of brand-name injectable medications that have the same active ingredients, dosage form, strength, and route of administration as their brand-name counterparts. These medications are often used in hospitals, clinics, and other healthcare settings to treat conditions such as infections, pain, and inflammation.


One of the key drivers of demand in the US generic injectables market is the cost savings associated with these medications. Generic injectables are typically less expensive than their brand-name counterparts, making them an attractive option for healthcare providers and patients looking to reduce healthcare costs. This cost savings is particularly important for patients who rely on injectable medications for chronic conditions, as it can help make treatment more affordable and accessible.


The US generic injectables market is also driven by the growing need for injectable medications across a wide range of therapeutic areas. Injectable medications are often used when oral medications are not effective or feasible, such as in cases of severe pain, nausea, or dehydration. As the population ages and the prevalence of chronic diseases increases, there is a growing demand for injectable medications to treat these conditions, driving further growth in the market.


The market for generic injectables in the US is highly competitive, with a large number of companies offering a wide range of products. Key players in the market include Pfizer, Teva Pharmaceuticals, Hospira, and Sandoz, among others. These companies invest heavily in research and development to introduce new generic injectables and improve existing products, driving innovation and growth in the market.


In recent years, there has been a growing focus on quality and safety in the US generic injectables market. Regulatory bodies such as the Food and Drug Administration (FDA) have implemented strict guidelines for the approval and manufacturing of generic injectables to ensure their safety, efficacy, and quality. This focus on quality has helped improve consumer confidence in generic injectables and drive further demand for these medications.


Overall, the demand for generic injectables in the US is expected to continue growing, driven by cost savings, the increasing need for injectable medications across therapeutic areas, and efforts to improve quality and safety. As the healthcare system seeks to provide high-quality care at a lower cost, generic injectables will remain a critical component of the treatment landscape, providing affordable and effective treatment options for patients across the country.

Report Scope:

Report Attribute/Metric Details
Market Size 2022 USD 79.5 billion
Market Size 2023 USD 83.6 billion
Market Size 2032 USD 124.59 Billion
Compound Annual Growth Rate (CAGR)  5.1% (2023-2030)
Base Year 2022
Market Forecast Period 2023-2032
Historical Data 2018 - 2021
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Material, Type, Design, End-User, and Region
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The U.S, Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled SCHOTT AG, BD, Gerresheimer AG, West Pharmaceutical Services Inc, AptarGroup Inc., Helvoet Rubber & Plastic Technologies B.V., Terumo Corporation, Nipro PharmaPackaging International Company.
Key Market Opportunities spending on health will get a huge boost
Key Market Dynamics Rising Demand for self-injection and related devices Rising numbers, incidence and prevalence of various chronic diseases




Key Questions Answered

  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample

Why Choose Market Research Future?

  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst
Leading companies partner with us for data-driven Insights.
Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo Client logo

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid